Xenothera Announces Publication in European Journal of Clinical Investigation on Immunological Mechanisms Underlining Use of LIS1

Kidney graft recipients receiving anti-lymphocyte globulins of animal origin undergo unwanted immune...

More

XENOTHERA to raise Series A

XENOTHERA has started to gather investors for a Series A round of...

More

XENOTHERA sponsors the realization of a fresco for the hospital by transplanted patients

Nantes, november 2017 The fresco, more than 8 meters long, has been...

More

XENOTHERA nominated for the Ernst&Young Entrepreneur Award

Nantes, September 2017 We have been selected for the 2017 entrepreneur awards...

More

Press Release: Start-up XENOTHERA closes a new capital increase above 2 million euros

June 10th, 2016 XENOTHERA, a young biotech who develops an innovative immunosuppressant,...

More

XENOTHERA moved to the Medicine Faculty of Nantes

September 1st, 2015 The Medicine Faculty of Nantes is welcoming the start-up...

More

XENOTHERA at Melbourne 2015 IXA

July 24th, 2015 Several partners of XENOTHERA will be present at the...

More

XENOTHERA at Biopharm America™ 2015

July 23th, 2015 XENOTHERA will participate in the Biopharm America that will...

More